ATE81006T1 - Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen. - Google Patents
Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen.Info
- Publication number
- ATE81006T1 ATE81006T1 AT87100195T AT87100195T ATE81006T1 AT E81006 T1 ATE81006 T1 AT E81006T1 AT 87100195 T AT87100195 T AT 87100195T AT 87100195 T AT87100195 T AT 87100195T AT E81006 T1 ATE81006 T1 AT E81006T1
- Authority
- AT
- Austria
- Prior art keywords
- diltiazem
- verapamil
- activity
- nifedipin
- administration
- Prior art date
Links
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 title abstract 2
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 title abstract 2
- 229960004166 diltiazem Drugs 0.000 title abstract 2
- 229960001722 verapamil Drugs 0.000 title abstract 2
- 208000006011 Stroke Diseases 0.000 abstract 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960001597 nifedipine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/818,505 US4654372A (en) | 1986-01-10 | 1986-01-10 | Method for using verapamil for treating stroke |
| EP87100195A EP0229644B1 (en) | 1986-01-10 | 1987-01-09 | Method of use for diltiazem, verapamil or nifedipine having activity for the treatment of stroke |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE81006T1 true ATE81006T1 (de) | 1992-10-15 |
Family
ID=25225695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87100195T ATE81006T1 (de) | 1986-01-10 | 1987-01-09 | Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4654372A (OSRAM) |
| EP (1) | EP0229644B1 (OSRAM) |
| JP (1) | JPS62167725A (OSRAM) |
| AT (1) | ATE81006T1 (OSRAM) |
| CA (1) | CA1284950C (OSRAM) |
| DE (1) | DE3781904T2 (OSRAM) |
| ES (1) | ES2046178T3 (OSRAM) |
| GR (1) | GR3005998T3 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871731A (en) * | 1987-10-07 | 1989-10-03 | Marion Laboratories, Inc. | Captopril and diltiazem composition and the like |
| DE3737741A1 (de) * | 1987-11-06 | 1989-05-18 | Goedecke Ag | Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid |
| KR0133553B1 (ko) * | 1989-06-16 | 1998-04-23 | 모리다 다까가즈 | 뇌기능 개선제 |
| RU1804845C (ru) * | 1991-02-15 | 1993-03-30 | Институт Органического Синтеза Латвийской Ан | Ноотропное вещество |
| US6083532A (en) | 1995-03-01 | 2000-07-04 | Duramed Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| US5695781A (en) * | 1995-03-01 | 1997-12-09 | Hallmark Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers |
| EP2322174B1 (en) * | 1998-07-10 | 2015-09-23 | Novartis Pharma AG | Combined use of valsartan and calcium channel blockers for therapeutic purposes |
| WO2008031831A2 (en) * | 2006-09-12 | 2008-03-20 | Neurosearch A/S | Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| US20220125754A1 (en) * | 2019-01-29 | 2022-04-28 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Treating the causative agent in adhesiogenesis |
| IL297333B2 (en) * | 2020-04-17 | 2025-09-01 | Honeybrains Llc | Preparations and methods for treating neuropsychiatric disorders |
| WO2026002967A1 (en) | 2024-06-24 | 2026-01-02 | Universität Linz | Leoligin and derivatives thereof as calcium channel blockers for the prevention and/or treatment of related diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4568677A (en) * | 1983-07-23 | 1986-02-04 | Pfizer Inc. | 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents |
| JPS60130517A (ja) * | 1983-12-16 | 1985-07-12 | Mitsui Pharmaceut Inc | アレルギ−性鼻炎治療剤 |
-
1986
- 1986-01-10 US US06/818,505 patent/US4654372A/en not_active Expired - Fee Related
- 1986-11-07 CA CA000522469A patent/CA1284950C/en not_active Expired - Fee Related
-
1987
- 1987-01-09 DE DE8787100195T patent/DE3781904T2/de not_active Expired - Fee Related
- 1987-01-09 JP JP62001981A patent/JPS62167725A/ja active Pending
- 1987-01-09 AT AT87100195T patent/ATE81006T1/de not_active IP Right Cessation
- 1987-01-09 ES ES87100195T patent/ES2046178T3/es not_active Expired - Lifetime
- 1987-01-09 EP EP87100195A patent/EP0229644B1/en not_active Expired - Lifetime
-
1992
- 1992-10-15 GR GR920402317T patent/GR3005998T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0229644A2 (en) | 1987-07-22 |
| EP0229644B1 (en) | 1992-09-30 |
| DE3781904D1 (de) | 1992-11-05 |
| CA1284950C (en) | 1991-06-18 |
| GR3005998T3 (OSRAM) | 1993-06-07 |
| JPS62167725A (ja) | 1987-07-24 |
| ES2046178T3 (es) | 1995-04-01 |
| EP0229644A3 (en) | 1989-11-23 |
| DE3781904T2 (de) | 1993-02-25 |
| US4654372A (en) | 1987-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69019488D1 (de) | Behandlung von Geflügel. | |
| DE3752141D1 (de) | Mittel zur behandlung von neuropathie | |
| DE3587741D1 (de) | Behandlung von Hautkrankheiten. | |
| ATE22657T1 (de) | Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung. | |
| ATE81006T1 (de) | Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen. | |
| DE3780091D1 (de) | Behandlung von pilzinfektionen. | |
| DE69018043D1 (de) | Behandlung von Geflügel. | |
| DE3674246D1 (de) | Behandlung von sauerem kohlenwasserstoffdestillat. | |
| DE3777861D1 (de) | Behandlung von gasen. | |
| DE3584560D1 (de) | Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen. | |
| DE3888994D1 (de) | Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen. | |
| DE3889416D1 (de) | Wärmebeständiges Schmiermittel zur Behandlung von Kunstfasern. | |
| ATE95694T1 (de) | Verwendung von bezafibrat zur behandlung von diabetes. | |
| AT382619B (de) | Verfahren zur herstellung von neuen optisch aktiven und racemischen trans- und/oder cis-1-(2'-(alkoxycarbonyl)-2'-(hydroxyimino) -aethyl)-1-alkyl-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)chinolizinen | |
| ATE71307T1 (de) | Verfahren zur behandlung von kontaktlinsen. | |
| DE3781279D1 (de) | Verfahren zur behandlung von blut. | |
| DE3751974D1 (de) | Serotonin-Antagonisten zur Behandlung von Wunden | |
| DE3751510D1 (de) | Düse zur Behandlung von Fäden. | |
| DE3486005D1 (de) | Anwendung von carbamate oder thiocarbamat-derivaten zur behandlung von fungus-infektionen. | |
| DE3865484D1 (de) | Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid. | |
| ATE178336T1 (de) | Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis | |
| ATE72115T1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a- | |
| DE3764168D1 (de) | Verfahren zur katalytischen hydrobehandlung von kohlenwasserstoffen. | |
| DE3764020D1 (de) | Verfahren zur katalytischen hydrobehandlung von kohlenwasserstoffen. | |
| SE9000658D0 (sv) | Mittel zur behandlung der schlaf-apnoe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |